• Home
  • curotrak
  • Clinical Trials: Navigating Challenges for Data Accuracy and Timely Monitoring

Clinical Trials: Navigating Challenges for Data Accuracy and Timely Monitoring

Clinical Trials

by Kathleen McQuade | Last Updated: November 14, 2023 | 1 min read

In all clinical trials, one of my ultimate goals is to obtain accurate, clean data as quickly and efficiently as possible – all while minimizing overall trial costs. Although the trial data results are the end goal, I never want to sacrifice subject safety to get it.

Subject safety is the reason we follow the International Conference on Harmonization (ICH) and Good Clinical Practice (GCP). Institutional Review Boards (IRBs) are in place as a means of ensuring we follow ICH/GCP throughout the life of a clinical trial.

What is Clinical Trial Management?

Clinical Trial Management is the organized process of overseeing and coordinating all aspects of a clinical trial, ensuring it runs smoothly and efficiently. This vital task involves planning, implementing, and monitoring the various stages of the trial.

It starts from recruiting participants to collecting and analyzing data. Skilled professionals in Clinical Trial Management play a crucial role in maintaining compliance with regulatory requirements and ethical standards, while also addressing any challenges that may arise during the trial. Their knowledge helps the study follow the plan, leading to better medical treatments being developed.

Successful Clinical Trial Management is key to producing reliable results that advance medical knowledge and enhance patient care. Starting a clinical trial requires extensive planning for good Clinical Trial Management. This is important in order to obtain accurate results and to help improve healthcare.

Ensuring Data Accuracy in Clinical Trials: The Vital Role of Third-Party Vendors

Data integrity assessment involves third-party vendors, usually clinical research organizations (CROs). They are crucial in monitoring and verifying information during clinical trials. They act as objective monitors, ensuring that all testing activities conform to the highest ethical and scientific standards.

To remove bias, third-party vendors monitor and verify clinical trial data. A vendor, usually a Clinical Research Organization (CRO), sends Site Managers (SMs) to monitor trial sites. During these visits, SMs review source data for accuracy and completeness.

Explore More Relevant Articles on P360

Critical Responsibilities of Clinical Trial Site Managers: Ensuring Data Integrity and Compliance

Data Integrity and Compliance

Third-party vendors must send site managers to clinical trial sites, which is a crucial responsibility. Site managers are the eyes and ears of the trial, responsible for overseeing all visits to the selected trial sites. During these visits, the site managers scrutinize the source data, checking for accuracy and completeness.

Site managers wear many different hats during their travels, including many important activities:

1. Follow the Protocol

Clinical Trial Site Managers tasked themselves with verifying whether the site staff followed the curriculum correctly. This is the cornerstone of data integrity, as any rotation can introduce errors and affect data reliability.

2. Principal Investigator Review

The Principal Investigator (PI) is the key person in any clinical trial, responsible for overall research. Site Managers conduct rigorous reviews of PI management to ensure testing accuracy and compliance with ethical and legal standards.

3. Drug liability

Pharmacy plays an important role in clinical trials by ensuring the proper management and distribution of reagents. Site Managers perform meticulous audits to maintain the highest possible audit.

4. Verification of on-site training

One of the pillars of data integrity is qualified site personnel. Site Managers make sure that the staff at a site are well-trained to carry out their duties effectively and efficiently.

5. Understanding of discrepancies

Site Managers are adept at spotting discrepancies and discrepancies in data. They work closely with on-site staff to resolve these issues quickly. This ensures the accuracy and completeness of the information.

6. To exit the site as 'audit-ready'.

At the end of their visit, Site Managers try to leave the site to be as ‘audit-ready’ as possible. The site is ready for auditing, ensuring data integrity, and following ICH and GCP principles.

Clinical trials are important for medical progress, giving necessary information to assess treatment safety and effectiveness. Well-organized studies with strict rules and guidelines involve people who volunteer to learn things that could change healthcare.

Clinical trials are crucial for determining the effectiveness of therapies and new medications, advancing the field of medicine.

Site Managers (SMs) ensure that site staff comply with the rules. They also verify that the Principal Investigator is overseeing the trial. Additionally, they monitor the drug inventory. Site Managers confirm that site staff have received adequate training.

Lastly, they assist in resolving any issues that may arise. After a visit, the Site Manager leaves the site as ‘audit-ready’ as possible.

Clinical Trial Site Managers have many responsibilities, so there are many ways clinical trial data delays can happen.

Unveiling Clinical Trial Challenges: Obstacles to Success and Data Integrity

We can only rely on clinical trial data entered after a site manager has verified it. It's important to have monitoring visits follow the schedule in the Clinical Monitoring Plan (CMP) / Clinical Operations Plan (COP). When these visits do not occur as scheduled, they result in delayed source document verification.

Untimely monitoring visits can create a multitude of problems during clinical trials. In my experience, a delay in Source Data Verification (SDV) has a negative chain effect. Other clinical departments (i.e., Safety, etc.) are unable to perform their review until after the SM has performed Source Data Verification.

Challenges in Clinical Trials: Navigating the Impact of Prolonged Source Data Verification (SDV)

Clinical Trial Challenges

In clinical trials, long Source Data Verification (SDV) triggers a series of challenging events. It is crucial to assign the verification of trial data to Site Managers (SMs) before reliance to ensure data integrity, compliance, and patient safety. The untimely inspection visits associated with delayed SDV can disrupt the clinical trial ecosystem in several ways:

1. Impact on other clinical departments

Timely visits interfere with the ability to review other medical departments such as safety inspections. Many agencies rely on the completion of the Source Data Verification before conducting their inspections. This bottleneck effect can significantly delay the overall testing process.

2. Extended Data Matching Time

The delay of the Source Data Verification extends the total time required for test data integration. This is not only time-saving but also efficient. Integrating data over time requires more resources and can be costly for drug sponsorship companies.

3. Increased Data Querying

The data control department may find itself asking for invalid or incorrect data. This process eats up valuable time and resources that could go towards more important tasks. Furthermore, too many queries can introduce errors and confusion in the data management process.

4. Security Concerns in Clinical Trails

In the SDV program, Site Managers frequently exhibit unreported adverse events (AEs) and serious adverse events (SAEs). This information has specific reporting requirements. including reporting to the sponsoring agency and the Institutional Review Board (IRB) at defined intervals for subject matter protection.

Optimizing Clinical Trials through Efficient Data Management and Timely Monitoring

This prolongs the time it takes for overall trial data balancing. The Data Management department may also spend an endless amount of time querying unverified/unclean data unnecessarily. This is not just a poor use of time but can be a very costly trial for pharmaceutical/sponsor companies.

During the Source Data Verification (SDV) process, site managers often find unreported Adverse Events (AEs) and/or Serious Adverse Events (SAEs). SAEs require reporting to the sponsor company and the IRB within specific timeframes. As mentioned earlier, subject safety is my highest priority during any clinical trial.

The difficulties arising from untimely inspection visits highlight the crucial need to follow Clinical Trial policies like CMP and CPO. It is essential to carry out monitoring visits as scheduled for various reasons:

  • SDV must be timely to ensure accurate and consistent data, minimize errors, and guarantee reliable results.

  • Promptly spotting and reporting Adverse Events (AEs) or Serious Adverse Events (SAEs) is crucial to ensure patient safety, as delayed reports can pose risks to individuals

  • Adherence to monitoring systems streamlines the testing process, reduces waste, and enhances overall efficiency.

Timely data processing is crucial to comply with regulatory standards and guidelines. Therefore, prompt assessment and documentation of Adverse Events (AEs) and/or Serious Adverse Events (SAEs) are imperative.

Failure to adhere to monitoring visit schedules outlined in the Clinical Monitoring Plan (CMP)/Clinical Operations Plan (COP) may result in delays in Source Data Verification (SDV). This results in unnoticed protocol deviations that could replicate for subsequent subjects during multiple visits.

Improving Clinical Trials: Smart Strategies for Efficiency
In today's tech world, there are lots of tools, like websites and apps, for setting calendar dates. We use an app called 'Time & Date Calculator' and its website to plan clinical trial visits. We put in the initial visit date and how long it should take, and the tools figure out when the next visits should be.

To help our social media team, we've made an Excel sheet with a special formula. This ensures that all members of the study team receive identical information available on the website. Whether we use the website or the app, the goal is to speed up how long it takes to look at trial data.

These steps help Contract Research Organizations (CROs) ensure that their staff follows the Clinical Monitoring Plan (CMP) and Clinical Operations Plan (COP) holding trial sites accountable. Pharmaceutical companies can also utilize these methods to verify CRO compliance with agreed-upon terms in trial monitoring contracts..

The main thing is finding the best way to send in good trial data on time. In the quick world of clinical trials, doing things efficiently is super important. Professionals are always looking for ways to make things easier.

Navigating Clinical Trial Hurdles: Streamlining Timely Monitoring

Addressing the challenge of just-in-time planning is crucial in the context of clinical trials. The timely monitoring of drug testing facilities is vital for ensuring data accuracy and subject safety.

Achieving this goal necessitates meticulous planning tailored to the specific requirements of the trial. Delays in the watch list during this crucial phase can slow down data availability and affect the trial timeline.

To overcome this challenge, industry professionals are increasingly adopting tools for clinical trial management. This clinical trial management software helps to streamline the monitoring process and enhance efficiency.

Streamlining Clinical Trial Management with Practical Solutions

Streamlining Clinical Trial Management

In the world of clinical trials, managing day-to-day operations effectively is crucial. A straightforward approach involves utilizing date-generation apps and websites. These easy-to-use tools streamline the process of scheduling check-ups. They consider the initial visit date and expected intervals to determine the schedule

Another practical option is employing Excel spreadsheets, offering clinicians a versatile platform for creating customized solutions. Clinicians can enhance Excel functionality for analyzing and planning by employing specialized formulas designed for testing purposes. This helps them to achieve customization to the unique needs of their clinical trial.

This Excel tool helps choose the initial arrival date, intervals, and testing parameters for precise analysis. It is a great tool for the clinical academic team to create monitoring systems that fit the trial's needs.

Explore our Clinical Trial Management System tool Curotrak for comprehensive problem-solving capabilities. Click below to discover how it can enhance your clinical trial management.

About P360

P360 offers a comprehensive perspective on the pharmaceutical ecosystem, integrating insights into the pharma industry, physicians, and patients. Specializing in devising strategic plans to expand sales, managing extensive datasets, prioritizing Pharma Sales reps and HCP engagement, and pioneering innovations through IoT technology. Leveraging cutting-edge technologies such as artificial intelligence and machine learning.

Curotrak is a complete patient lifecycle management solution. Curotrak handles everything from the first enrollment call to patient therapy adherence. Curotrak leverages advanced technologies to optimize patient engagement, data management, and decision-making throughout the clinical trial process. P360's dedication to transforming the healthcare industry with comprehensive, technology-driven solutions is evident.